Finance

Lists
A58:ETR
Elevance Health Inc
381,30 €
+0,87%
(+3,30) 1D
14-окт., 17:35:56 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for A58...
Open
379,60 €
High
382,50 €
Low
379,60 €
Mkt. cap
92,23 млд
Avg. vol.
11,00
Volume
20,00
52-wk high
382,50 €
52-wk low
241,60 €
No. of employees
97 миң
Open
379,60 €
High
382,50 €
Low
379,60 €
Mkt. cap
92,23 млд
Avg. vol.
11,00
Volume
20,00
52-wk high
382,50 €
52-wk low
241,60 €
No. of employees
97 миң
News stories
From web sources and news partners
Profile
Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans. Based on its 2021 revenues, the company ranked 20th on the 2022 Fortune 500. In 2023, the company's seat in Forbes Global 2000 rankings was 78. Carelon Global Solutions, Elevance Health's Business Process Outsourcing /Shared Services subsidiary, serves the group's offshore and customer service management. It operates sites in India, Puerto Rico, Philippines, and the United States. Wikipedia
About Elevance Health Inc
CEOGail Koziara Boudreaux
Employees96,6 миң
Founded1944
HeadquartersИндианаполис, Индиана, Америка Кошмо Штаттары
SectorHealth care provider
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
50,71 млд
49,75 млд
50,18 млд
50,47 млд
Cost of goods sold
38,14 млд
38,06 млд
35,62 млд
37,02 млд
Cost of revenue
38,14 млд
38,06 млд
35,62 млд
37,02 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,65 млд
10,75 млд
11,79 млд
11,04 млд
Operating expense
10,81 млд
10,92 млд
11,90 млд
11,15 млд
Total operating expenses
48,95 млд
48,98 млд
47,52 млд
48,17 млд
Operating income
1,76 млд
766,00 млн
2,66 млд
2,30 млд
Other non operating income
-
-
-
-
EBT including unusual items
1,41 млд
215,00 млн
2,30 млд
1,94 млд
EBT excluding unusual items
1,41 млд
399,00 млн
2,30 млд
1,94 млд
Income tax expense
219,00 млн
-331,00 млн
544,00 млн
483,00 млн
Effective tax rate
15,58%
-153,95%
23,61%
24,94%
Other operating expenses
-
-
-
-
Net income
1,19 млд
547,00 млн
1,76 млд
1,46 млд
Net profit margin
2,34%
1,10%
3,52%
2,90%
Earnings per share
6,03
3,33
12,58
7,45
Interest and investment income
-
-
-
-
Interest expense
-351,00 млн
-367,00 млн
-357,00 млн
-364,00 млн
Net interest expenses
-351,00 млн
-367,00 млн
-357,00 млн
-364,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
2,14 млд
1,17 млд
3,02 млд
2,67 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору